I agree @eyeinthesky there was not much we hadn't heard in the previous presentation.However....
I have a few salient points/reminders to share - all of which should be music to the ears of holders
- "We do believe we have a unique opportunity to build a world-class asset"
- "We have a bold ambition, Liontown wants to be a world-class Battery metals producer."
- ESG is critical for success and the company is committed to delivering on this.
- "Kathleen Valley is clearly a Tier 1 resource"
- "Targetting a premium product greater than 6% (Li20)"
- Tony confirmed the timeline has been moved forward so that KV will be in production Quarter 2 of 2024.
- Liontown wants to create long-term sustainable shareholder value.
- Board and Executive Team's skin in the game (21%) is aligned to shareholder interests.
- Tony also paid tribute to the significant contribution of David Richards. The Moora /LSA Koojan project is highly prospective, superbly located with great potential and Tony reiterated that having David R as CEO and MD that the new entity will be in very safe hands.
- Forums
- ASX - By Stock
- LTR
- ASX Today
ASX Today, page-5573
-
- There are more pages in this discussion • 36,044 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LTR (ASX) to my watchlist
(20min delay)
|
|||||
Last
99.5¢ |
Change
-0.005(0.50%) |
Mkt cap ! $2.418B |
Open | High | Low | Value | Volume |
$1.03 | $1.03 | 98.0¢ | $7.565M | 7.556M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
21 | 115308 | 99.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.00 | 200668 | 26 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
21 | 115308 | 0.995 |
33 | 436001 | 0.990 |
17 | 286985 | 0.985 |
46 | 365617 | 0.980 |
8 | 702081 | 0.975 |
Price($) | Vol. | No. |
---|---|---|
1.000 | 229791 | 26 |
1.005 | 219744 | 15 |
1.010 | 480515 | 28 |
1.015 | 376368 | 5 |
1.020 | 184174 | 14 |
Last trade - 13.52pm 15/07/2024 (20 minute delay) ? |
Featured News
LTR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online